key: cord-0902375-5rn1hllu authors: Yang, Rongrong; Gui, Xien; Xiong, Yong title: Patients with respiratory symptoms are at greater risk of COVID-19 transmission date: 2020-03-14 journal: Respir Med DOI: 10.1016/j.rmed.2020.105935 sha: cf8a4ad66f03cdc3d3572eb3b870f3f9b18809f3 doc_id: 902375 cord_uid: 5rn1hllu nan The situation with the ongoing epidemic of coronavirus disease 2019 (COVID-19) that started in Wuhan, China, continued to rapidly evolve. As of 10 March 2020, China had confirmed 80 754 cases of COVID-19 and there had been 3136 deaths. Except for China, 109 other nations have reported 32 555 cases and 878 deaths. The clinical and laboratory characteristics of hospitalized COVID-19 patients were described [1, 2] . Cough is one of the most common symptoms at onset of illness [3] . Here, we described the differences in characteristics of nasopharyngeal swab detection between patients with and without respiratory symptoms. The 82 COVID-19 patients were divided into respiratory symptoms group (26 cases) and non-respiratory symptoms group (56 cases). The two groups were comparable in gender (11 [ We believe that patients with respiratory symptoms are more harmful to close contacts. First, the virus can be shed explosively from the COVID-19 patients' upper respiratory tract into the air through coughing. Second, the duration of virus shedding from nasopharynx was longer. It is an effective precaution to stop droplets spreading by hand or with towel when coughing. After coughing, the importance of frequent and proper hand hygiene should be emphasized. Moreover, strict precautions must be observed when handling the towel contaminated with spittle. One encouraging finding is that the results of nasopharyngeal swabs are more stable in patients with cough symptoms. The incidence of nasopharyngeal swabs testing shown as negative and positive fluctuating repeatedly is less, which provides a basis for clinicians to better grasp the appropriate time to cancel quarantine based on the results of asopharyngeal swabs. Supported by Medical Science Advancement Program (Basical Medical Sciences) of Wuhan University, Grant NO. TFJC2018002. We declare no competing interests. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China Clinical characteristics of coronavirus disease 2019 in China Clinical features of patients infected with 2019 novel coronavirus in